Recommendation ID
IPG522/1
Question

NICE encourages further research into hysteroscopic morcellation of uterine leiomyomas (fibroids) which could include data collection with publication of the findings, particularly of safety outcomes. Patient selection should be clearly described. Outcomes should include symptom relief, quality of life, recurrence rates and information about fertility and subsequent pregnancies. All complications should be documented. NICE may update the guidance on publication of further evidence.

Any explanatory notes
(if applicable)

Current evidence on the efficacy of hysteroscopic morcellation of uterine leiomyomas (fibroids) is limited in quality and quantity. Evidence on safety shows potential for serious complications. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research.


Source guidance details

Comes from guidance
Hysteroscopic morcellation of uterine leiomyomas (fibroids)
Number
IPG522
Date issued
June 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No